Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
All content for BioBoss is the property of John Simboli and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, shares his insights about leadership in biopharma and how 60 Degrees Pharmaceuticals is working to develop vital medicines to treat and prevent infectious diseases.
BioBoss
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
